KRAS and breast cancer: Rescue experiments showed that when GPR110 was overexpressed in MCF-7 cells, which represent a luminal type of breast cancer, the expression of EMT and CSC markers and regulators increased, while their expression was inhibited when KRAS expression was knocked down in GPR110-overexpressing MCF-7 cells.